Abstract
The intricate interplay between the endothelium and immune cells has been well recognized in the context of immune responses. However, the fact that this inter-relation extends well beyond immune regulation is becoming increasingly recognized, with particular regards to the influence of the immune system on the essential endothelial process of angiogenesis, where the contribution of cytokines drives the angiogenic process. As angiogenesis is an important component of numerous pathological states, among these chronic inflammatory conditions and cancer, understanding the role of cytokines and chemokines in guiding new vessel formation provides key insight into novel therapeutic modalities. Here we review the actions of principal cytokines and chemokines on the angiogenic process and discuss how both can be considered potential pharmaceutical targets or pharmaceuticals themselves for modulation of angiogenesis in chronic inflammation associated with cancer, rheumatoid arthritis and other inflammatory diseases.
Keywords: neutrophil, monocyte, macrophage, angiogenesis, chemokine, cytokine
Current Pharmaceutical Design
Title: Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease
Volume: 12 Issue: 24
Author(s): R. Benelli, G. Lorusso, A. Albini and D. M. Noonan
Affiliation:
Keywords: neutrophil, monocyte, macrophage, angiogenesis, chemokine, cytokine
Abstract: The intricate interplay between the endothelium and immune cells has been well recognized in the context of immune responses. However, the fact that this inter-relation extends well beyond immune regulation is becoming increasingly recognized, with particular regards to the influence of the immune system on the essential endothelial process of angiogenesis, where the contribution of cytokines drives the angiogenic process. As angiogenesis is an important component of numerous pathological states, among these chronic inflammatory conditions and cancer, understanding the role of cytokines and chemokines in guiding new vessel formation provides key insight into novel therapeutic modalities. Here we review the actions of principal cytokines and chemokines on the angiogenic process and discuss how both can be considered potential pharmaceutical targets or pharmaceuticals themselves for modulation of angiogenesis in chronic inflammation associated with cancer, rheumatoid arthritis and other inflammatory diseases.
Export Options
About this article
Cite this article as:
Benelli R., Lorusso G., Albini A. and Noonan M. D., Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease, Current Pharmaceutical Design 2006; 12 (24) . https://dx.doi.org/10.2174/138161206777947461
DOI https://dx.doi.org/10.2174/138161206777947461 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Maternal Fish Oil Supplementation: The Prodrom of Synaptic Protection in Alzheimers Disease
Current Nutrition & Food Science Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age
Current Pharmaceutical Design Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
Current Topics in Medicinal Chemistry The Long and Winding Road: Searching for Non-MHC Psoriasis Susceptibility Loci
Current Genomics Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics
Current Pharmaceutical Design Endometriosis and Perinatal Outcome - A Systematic Review of the Literature
Current Women`s Health Reviews The Function of the Selective Inhibitors of Cycloxygenase 2
Mini-Reviews in Medicinal Chemistry The Immune-Endocrine-Metabolic Unit During Human Tuberculosis
Current Immunology Reviews (Discontinued) CARD Proteins as Therapeutic Targets in Cancer
Current Drug Targets Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy
Current Cancer Drug Targets IL-24: Physiological and Supraphysiological Effects on Normal and Malignant Cells
Current Medicinal Chemistry Gene Therapy for Osteoinduction
Current Gene Therapy Anti-Aging Property of G2013 Molecule as a Novel Immunosuppressive Agent on Enzymatic and Non-Enzymatic Oxidative Stress Determinants in Rat Model
Current Drug Discovery Technologies MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Polyphenols: Potential Future Arsenals in the Treatment of Diabetes
Current Pharmaceutical Design Macrophage Inflammatory Protein 1 and CCR5 as Attractive Therapeutic Targets for HIV Infection
Recent Patents on Anti-Infective Drug Discovery “Virostatics” as a Potential New Class of HIV Drugs
Current Pharmaceutical Design Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypoxia Upregulates MAPK<sup>p38</sup>/MAPK<sup>ERK</sup> Phosphorylation In Vitro: Neuroimmunological Differential Time-Dependent Expression of MAPKs
Protein & Peptide Letters General Molecular Biology and Architecture of Nuclear Receptors
Current Topics in Medicinal Chemistry